Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

Allergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an
immunoglobulin E (IgE)-mediated inflammation of the membranes lining the nose (1). It was …

Allergic rhinitis is clinically defined as a symptomatic disorder of the nose induced by an IgE-
mediated inflammation after allergen exposure of the membranes lining the nose. Symptoms …

The nomenclature proposed in the October 2003 report of the Nomenclature Review
Committee of the World Allergy Organization is an update of the European Academy of …

Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom
allergy are well established; however, clinical contraindications to AIT are not always well …

Background Investigations meeting current standards are limited for the effect of house dust
mite (HDM) allergy immunotherapy in asthmatic patients. Objective This trial investigated the …

This paper was produced to establish a common European Standard for Practical Allergen-
Specific Immunotherapy that could serve as an overall Ôgold standardÕ to ensure optimum …

Background This is an update of a Cochrane Review first published in The Cochrane Library
in Issue 2, 2003. Allergic rhinitis is a common condition which can significantly impair quality …

BACKGROUND: Allergen-specific immunotherapy uses aqueous extracts of natural source
materials as a basis for preparations to downregulate the allergic response. Recombinant …

abstract Asthma is characterized by chronic airway inflammation, variable airway narrowing,
and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and …